지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.11
- 수록면
- 631 - 638 (8page)
- DOI
- https://doi.org/10.4111/icu.20220056
이용수
초록· 키워드
오류제보하기
Purpose: The aim of this study was to evaluate the effectiveness of the Prostate Health Index (PHI) and prostate multi-parametric magnetic resonance imaging (mpMRI) in predicting prostate cancer (PCa) and clinically significant prostate cancer (csPCa) during initial prostate biopsy.
Materials and Methods: In total, 343 patients underwent initial prostate biopsy and were screened by use of PHI and prostate-specific antigen (PSA) levels between April 2019 and July 2021. A subgroup of 232 patients also underwent prostate mpMRI. Logistic regression analysis was performed to evaluate the accuracies of PSA, PHI, and mpMRI as predictors of PCa or csPCa. These predictive accuracies were quantified by using the area under the receiver operating characteristic curve. The different predictive models were compared using the DeLong test.
Results: Logistic regression showed that age, PSA, PHI, and prostate volume were significant predictors of both PCa and csPCa. In the mpMRI subgroup, age, PSA level, PHI, prostate volume, and mpMRI were predictors of both PCa and csPCa. The PHI (area under the curve [AUC]=0.693) was superior to the PSA level (AUC=0.615) as a predictor of PCa (p=0.038). Combining PHI and mpMRI showed the most accurate prediction of both PCa and csPCa (AUC=0.833, 0.881, respectively).
Conclusions: The most accurate prediction of both PCa and csPCa can be performed by combining PHI and mpMRI. In the absence of mpMRI, PHI is superior to PSA alone as a predictor of PCa, and adding PHI to PSA can increase the detection rate of both PCa and csPCa.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
Investigative and Clinical Urology
2016 .01
-
Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists
Investigative and Clinical Urology
2015 .01
-
Diagnostic Performance of %[-2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-institutional Study
Journal of Korean Medical Science
2018 .01
-
Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer
Investigative and Clinical Urology
2019 .01
-
A Predictive Model Based on Bi-parametric Magnetic Resonance Imaging and Clinical Parameters for Clinically Significant Prostate Cancer in the Korean Population
Cancer Research and Treatment
2021 .10
-
Comparison of the Formula of PSA, Age, Prostate Volume and Race Versus PSA Density and the Detection of Primary Malignant Circulating Prostate Cells in Predicting a Positive Initial Prostate Biopsy in Chilean Men with Suspicion of Prostate Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
The national-wide incidence of prostate-specific antigen testing trend for a decade in Korea by age group
Investigative and Clinical Urology
2022 .03
-
Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study
Investigative and Clinical Urology
2020 .01
-
Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5–10 ng/mL
Investigative and Clinical Urology
2020 .01
-
Prostate Cancer Screening in the Fit Chilean Elderly: a Head to Head Comparison of Total Serum PSA versus Age Adjusted PSA versus Primary Circulating Prostate Cells to Detect Prostate Cancer at Initial Biopsy
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Trends of stratified prostate cancer risk in a single Korean province from 2003 to 2021: A multicenter study conducted using regional training hospital data
Investigative and Clinical Urology
2023 .03
-
전립선의 염증반응과 전립선특이항원의 변화
Urogenital Tract Infection
2015 .01
-
Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Exponential Rise in Prostate-Specific Antigen (PSA) during Anti-Androgen Withdrawal Predicts PSA Flare after Docetaxel Chemotherapy in Patients with Castration-Resistant Prostate Cancer
Yonsei Medical Journal
2015 .01
-
전립선암의 영상의학적 소견
대한의사협회지
2015 .01
-
Predictors of Participation in Prostate Cancer Screening among Older Men in Jordan
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Effect of training and individual operator's expertise on prostate cancer detection through prostate biopsy: Implications for the current quantitative training evaluation system
Investigative and Clinical Urology
2021 .11
-
전립샘 특이항원을 이용한 국가암 선별 검사의 당위성
대한의사협회지
2020 .01
-
Impact of birth season on second-to-fourth digit ratio, prostate volume, and prostate cancer
Investigative and Clinical Urology
2022 .03
-
Prevalence and clinical significance of incidental 18F-fluoro-2-deoxyglucose uptake in prostate
Investigative and Clinical Urology
2015 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0